HR0394 LRB094 12269 DRJ 46004 r

1
HOUSE RESOLUTION

 
2     WHEREAS, In January 2005, the State of Illinois, through
3 its representatives in the Office of the Governor, signed a
4 $2.6 million contract with Ecosse Hospital Products Limited of
5 England for the purchase of 300,000 doses of influenza vaccine;
6 and
 
7     WHEREAS, The start date on the contract was retroactive to
8 October 20, 2004; and
 
9     WHEREAS, The State of Illinois has not received the
10 contracted-for vaccine; and
 
11     WHEREAS, In October 2004, the I-SaveRx program was created
12 to allow Illinois citizens to obtain prescription drugs through
13 a network of pharmacies in Canada, the United Kingdom, and
14 Ireland; and
 
15     WHEREAS, In Executive Order 2003-15, the Governor
16 established a Special Advocate for Prescription Drugs; and
 
17     WHEREAS, The Office of the Governor and the Special
18 Advocate for Prescription Drugs have been involved in the flu
19 vaccine procurement process and in the I-SaveRx and other
20 prescription drug programs; and
 
21     WHEREAS, There are questions concerning the State's
22 obligation to pay on a contract for which the purchased goods
23 were not received and for which the State did not receive any
24 benefit; and
 
25     WHEREAS, Enrollment in the I-SaveRx program has been low;
26 therefore, be it
 
27     RESOLVED, BY THE HOUSE OF REPRESENTATIVES OF THE

 

 

HR0394 - 2 - LRB094 12269 DRJ 46004 r

1 NINETY-FOURTH GENERAL ASSEMBLY OF THE STATE OF ILLINOIS, that
2 the Auditor General shall conduct a management audit of the
3 process followed in negotiating and entering into the contract
4 with Ecosse Hospital Products Limited and in establishing and
5 operating the I-SaveRx program; and be it further
 
6     RESOLVED, That the audit include, but not be limited to,
7 the following determinations:
8         (1) The roles played by the Office of the Governor and
9     the Special Advocate for Prescription Drugs in negotiating
10     and entering into the flu vaccine contract;
11         (2) The procedures applicable to, and agencies
12     responsible for, the establishment and operation of the
13     I-SaveRx program; and
14         (3) Whether the entities involved in these programs
15     followed all applicable laws, regulations, policies, and
16     procedures; and be it further
 
17     RESOLVED, That the Office of the Governor, the Office of
18 the Special Advocate for Prescription Drugs, and any other
19 entity that may have relevant information pertaining to this
20 audit cooperate fully and promptly with the Auditor General's
21 Office in the conduct of this audit; and be it further
 
22     RESOLVED, That the Auditor General commence this audit as
23 soon as possible and report his findings and recommendations
24 upon completion in accordance with Section 3-14 of the Illinois
25 State Auditing Act.